Log in
Enquire now
‌

US Patent 11661441 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Apellis Pharmaceuticals
Apellis Pharmaceuticals
0
Current Assignee
Apellis Pharmaceuticals
Apellis Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116614410
Date of Patent
May 30, 2023
0
Patent Application Number
172047420
Date Filed
March 17, 2021
0
Patent Citations
‌
US Patent 10308687 Cell-penetrating compstatin analogs and uses thereof
0
‌
US Patent 10407466 Methods of selecting compstatin mimetics
0
‌
US Patent 10875893 Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
0
‌
US Patent 10941184 Cell-penetrating compstatin analogs and uses thereof
0
‌
US Patent 11001610 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
0
‌
US Patent 11040107 Dosing regimens and related compositions and methods
0
‌
US Patent 11407789 Cell-penetrating compstatin analogs and uses thereof
0
‌
US Patent 11292815 Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
0
...
Patent Primary Examiner
‌
Jeanette M Lieb
0
CPC Code
‌
C07K 14/472
0
‌
C07K 7/64
0
‌
A61K 38/08
0
‌
A61K 47/60
0
‌
C07K 7/08
0

In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11661441 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.